K A Bush Selected Research

Opioid Analgesics (Opioids)

9/2001	The kappa-opioid agonist, asimadoline, alters cytokine gene expression in adjuvant arthritis.
6/2000	Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K A Bush Research Topics

Disease

5	Arthritis (Polyarthritis) 07/2004 - 06/2000
4	Experimental Arthritis 07/2004 - 03/2001
3	Rheumatoid Arthritis 07/2004 - 01/2002
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 09/2009
1	Inflammation (Inflammations) 07/2004
1	Necrosis 09/2001
1	Disease Progression 03/2001

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 07/2004 - 03/2001
4	Messenger RNA (mRNA)IBA 07/2004 - 06/2000
2	asimadolineIBA 09/2001 - 06/2000
2	Opioid Analgesics (Opioids)IBA 09/2001 - 06/2000
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2001 - 03/2001
2	Interleukin-17 (Interleukin 17)IBA 09/2001 - 03/2001
1	Fibronectins (Fibronectin)IBA 09/2009
1	Biocompatible Materials (Biomaterials)IBA 09/2009
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	ImmunosorbentsIBA 07/2004
1	Prednisolone (Predate)FDA LinkGeneric 07/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	Biomarkers (Surrogate Marker)IBA 07/2004
1	Interleukin-6 (Interleukin 6)IBA 07/2004
1	EnzymesIBA 07/2004
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2002
1	NeuropeptidesIBA 06/2000
1	Substance PIBA 06/2000

Therapy/Procedure

2	Therapeutics 03/2002 - 01/2002
1	Aftercare (After-Treatment) 01/2002